Results 11 to 20 of about 1,322,570 (292)

Vaccine trials during a pandemic: potential approaches to ethical dilemmas

open access: yesTrials, 2021
Ever since the emergence of the coronavirus disease 2019 (COVID-19), global public health infrastructures and systems, along with community-wide collaboration and service, have risen to an unprecedented challenge.
Manaf Alqahtani   +3 more
doaj   +1 more source

Diagnosis and Management of COVID-19 Disease [PDF]

open access: yes, 2020
SARS-CoV-2 is a novel coronavirus that was identified in late 2019 as the causative agent of COVID-19 (aka coronavirus disease 2019). On March 11, 2020, the World Health Organization (WHO) declared the world-wide outbreak of COVID-19 a pandemic.
Carlos, Graham   +5 more
core   +1 more source

Everyday Life and Everyday Communication in Coronavirus Capitalism [PDF]

open access: yes, 2020
In 2020, the coronavirus crisis ruptured societies and their everyday life around the globe. This article is a contribution to critically theorising the changes societies have undergone in the light of the coronavirus crisis.
Fuchs, Christian, Fuchs, Christian
core   +1 more source

COVID-19 Associated Rhino-Orbital Mucormycosis Complicated by Gangrenous and Bone Necrosis—A Case Report from Honduras

open access: yesVaccines, 2021
Background: Mucormycosis is a life-threatening invasive fungal infection most commonly observed in immunocompromised patients. Throughout the COVID-19 pandemic, a growing number of Mucorales associated infections, now termed COVID-19 associated ...
Elsa Yolanda Palou   +13 more
doaj   +1 more source

Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells [PDF]

open access: yes, 2018
Canine respiratory coronavirus (CRCoV), identified in 2003, is a member of the Coronaviridae family. The virus is a betacoronavirus and a close relative of human coronavirus OC43 and bovine coronavirus.
A Milewska   +75 more
core   +7 more sources

Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis

open access: yesCell & Bioscience, 2022
Background Thrombosis and coagulopathy are pervasive pathological features of coronavirus disease 2019 (COVID-19), and thrombotic complications are a sign of severe COVID-19 disease and are associated with multiple organ failure and increased mortality ...
Weiping Ji   +9 more
doaj   +1 more source

Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3–12 Years Old

open access: yesVaccines, 2022
Background and Objectives: In the current COVID-19 pandemic, children below the age of 12 could manifest COVID-19 symptoms and serve as a reservoir for the virus in the community.
Khaled Greish   +13 more
doaj   +1 more source

Comparison of COVID-19 Vaccination Rollout Approaches across Canada

open access: yesHealth Reform Observer - Observatoire des Réformes de Santé, 2023
Across Canada, there were notable differences in the rollout of provincial/territorial COVID-19 vaccination programs, reflecting diverse sociodemographic profiles, geopolitical landscapes, health system designs, and pandemic experiences.
Tiffany Fitzpatrick   +7 more
doaj  

Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study

open access: yeseJHaem, 2021
Introduction Studies that examine the association between sickle cell disease (SCD) and COVID‐19 outcomes are lacking. This study aims to determine whether SCD is a risk factor for severe COVID‐19 infection in regard to the requirement of noninvasive ...
Abdulkarim Abdulrahman   +7 more
doaj   +1 more source

Epidemiological assessment of SARS-CoV-2 reinfection

open access: yesInternational Journal of Infectious Diseases, 2022
Objectives: SARS-CoV-2 vaccination has been shown to reduce infection severity; however, the reinfection frequency among unvaccinated, partially vaccinated, and fully vaccinated individuals remains unclear.
Marwa Almadhi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy